These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 9516965)

  • 21. Determination of tiamenidine in biological specimens by radioimmunoassay.
    Eckert HG; Baudner S; Weimer KE; Wissmann H
    Arzneimittelforschung; 1981; 31(3):419-24. PubMed ID: 7194666
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Direct micro-radioimmunoassay of the new renin inhibitor CGP 60536.
    Lefévre G; Duval M; Poncin A
    J Immunoassay; 2000 Feb; 21(1):65-84. PubMed ID: 10805319
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Radioimmunoassay and plasma concentrations of the anti-allergenic agent, 2-methoxy-11-oxo-11-H-pyrido[2,1-b]quinazoline-8-carboxylic acid in man.
    Dixon R; Lucek R; Liu YY; Colburn W; Parsonnet M
    Res Commun Chem Pathol Pharmacol; 1980 Oct; 30(1):163-70. PubMed ID: 7433765
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunoassay for biochanin A.
    Lapcík O; Vítková M; Klejdus B; Al-Maharik N; Adlercreutz H
    J Immunol Methods; 2004 Nov; 294(1-2):155-63. PubMed ID: 15604024
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phase I and pharmacokinetic study of LY309887: a specific inhibitor of purine biosynthesis.
    Budman DR; Johnson R; Barile B; Bowsher RR; Vinciguerra V; Allen SL; Kolitz J; Ernest CS; Kreis W; Zervos P; Walling J
    Cancer Chemother Pharmacol; 2001 Jun; 47(6):525-31. PubMed ID: 11459206
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A phase I and pharmacokinetic study of 1843U89, a noncompetitive inhibitor of thymidylate synthase, in patients with advanced solid malignancies.
    Schwartz G; Johnson TR; Goetz A; Burris H; Smetzer L; Lampkin T; Sailstad J; Hohneker JA; Von Hoff DD; Rowinsky EK
    Clin Cancer Res; 2001 Jul; 7(7):1901-11. PubMed ID: 11448903
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phase I study of the antipurine antifolate lometrexol (DDATHF) with folinic acid rescue.
    Sessa C; de Jong J; D'Incalci M; Hatty S; Pagani O; Cavalli F
    Clin Cancer Res; 1996 Jul; 2(7):1123-7. PubMed ID: 9816277
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A phase II trial of pemetrexed in advanced breast cancer: clinical response and association with molecular target expression.
    Gomez HL; Santillana SL; Vallejos CS; Velarde R; Sanchez J; Wang X; Bauer NL; Hockett RD; Chen VJ; Niyikiza C; Hanauske AR
    Clin Cancer Res; 2006 Feb; 12(3 Pt 1):832-8. PubMed ID: 16467096
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of a synthetic peptide-based tartrate-resistant acid phosphatase radioimmunoassay for the measurement of bone resorption in rat serum.
    Srivastava AK; Libanati C; Lane N; Baylink DJ
    J Bone Miner Metab; 2002; 20(2):66-72. PubMed ID: 11862527
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A radioimmunoassay to measure piretanide in human serum and urine.
    Heptner W; Baudner S; Dagrosa EE; Hellstern C; Irmisch R; Strecker H; Wissmann H
    J Immunoassay; 1984; 5(1-2):13-27. PubMed ID: 6715550
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Radioimmunoassay of the antitumor drug--methotrexate (MTX)].
    Chen ZZ
    Zhonghua Zhong Liu Za Zhi; 1985 Nov; 7(6):414-6. PubMed ID: 3836843
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enzyme inhibition, polyglutamation, and the effect of LY231514 (MTA) on purine biosynthesis.
    Mendelsohn LG; Shih C; Chen VJ; Habeck LL; Gates SB; Shackelford KA
    Semin Oncol; 1999 Apr; 26(2 Suppl 6):42-7. PubMed ID: 10598554
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of the kinetic mechanism of Escherichia coli glycinamide ribonucleotide transformylase.
    Shim JH; Benkovic SJ
    Biochemistry; 1998 Jun; 37(24):8776-82. PubMed ID: 9628739
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Catalytic mechanism of Escherichia coli glycinamide ribonucleotide transformylase probed by site-directed mutagenesis and pH-dependent studies.
    Shim JH; Benkovic SJ
    Biochemistry; 1999 Aug; 38(31):10024-31. PubMed ID: 10433709
    [TBL] [Abstract][Full Text] [Related]  

  • 35. X-ray crystal structure of glycinamide ribonucleotide synthetase from Escherichia coli.
    Wang W; Kappock TJ; Stubbe J; Ealick SE
    Biochemistry; 1998 Nov; 37(45):15647-62. PubMed ID: 9843369
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 5,10-Methenyltetrahydrofolate synthetase activity is increased in tumors and modifies the efficacy of antipurine LY309887.
    Field MS; Anguera MC; Page R; Stover PJ
    Arch Biochem Biophys; 2009 Jan; 481(2):145-50. PubMed ID: 19022216
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stereospecific radioimmunoassay of alpha-l-acetylmethadol (LAAM).
    McGilliard KL; Olsen GD
    J Pharmacol Exp Ther; 1980 Oct; 215(1):205-12. PubMed ID: 7452485
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development and analytic validation of a radioimmunoassay for the quantification of canine calprotectin in serum and feces from dogs.
    Heilmann RM; Suchodolski JS; Steiner JM
    Am J Vet Res; 2008 Jul; 69(7):845-53. PubMed ID: 18593232
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Production and properties of antiserum for radioimmunoassay of serum conjugated chenodeoxycholic acid and its preliminary application.
    Orbán EC; Pallos JP; Kocsár LT
    Acta Med Hung; 1985; 42(1-2):77-84. PubMed ID: 4034340
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of a radioimmunoassay for the anthrapyrazole chemotherapy agent CI-937 and the pharmacokinetics of CI-937 in rats.
    Nordblom GD; Pachla LA; Chang T; Whitfield LR; Showalter HD
    Cancer Res; 1989 Oct; 49(19):5345-51. PubMed ID: 2766301
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.